medigraphic.com
ISSN 0028-3851 (Print)

2023, Number 3

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2023; 51 (3)

Refractory acute disseminated encephalomyelitis after vaccination against SARS-CoV-2

Tovar SLP, Torres RCM, Sicsik AMA, Rodríguez HA, Navarro EBM, Núñez OL

Language: Spanish
References: 10
Page: 151-156
PDF size: 274.85 Kb.


ABSTRACT

Acute disseminated encephalomyelitis (ADEM) is an autoimmune disease that causes demyelinating lesions in the brain and spinal cord, presenting a wide clinical spectrum. Different precipitants for the development of this disease have been described, one of them being vaccination. During the health contingency due to COVID-19, the development of vaccines has helped in the control of cases, as well as in reducing the severity of the disease. However, an association has been observed between the development of acute disseminated encephalomyelitis and vaccination and infection by COVID-19. We present the case of a young man with a negative PCR test for SARS-CoV-2 who presented disorientation and weakness 24 hours after the application of the ChAdOx1-S vaccine.


REFERENCES

  1. Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013; 19 (10): 1261-1267.

  2. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 2016; 87 (9 Suppl 2): S38-S45.

  3. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci 2008; 15 (12): 1315-1322.

  4. Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol. 2022; 362: 577765.

  5. Al-Quliti K, Qureshi A, Quadri M, Abdulhameed B, Alanazi A, Alhujeily R. Acute demyelinating encephalomyelitis post-COVID-19 vaccination: a case report and literature review. Diseases. 2022; 10 (1): 13.

  6. Rinaldi V, Bellucci G, Romano A, Bozzao A, Salvetti M. ADEM after ChAdOx1 nCoV-19 vaccine: a case report. Mult Scler. 2022; 28 (7): 1151-1154.

  7. Li X, Raventós B, Roel E, Pistillo A, Martinez-Hernandez E, Delmestri A et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022; 376: e068373.

  8. Permezel F, Borojevic B, Lau S, de Boer HH. Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination. Forensic Sci Med Pathol. 2022; 18 (1): 74-79.

  9. Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J et al. Coronavirus pandemic (COVID-19). Published online at OurWorldInData.org. 2020. Retrieved from: https://ourworldindata.org/coronavirus

  10. Menge T, Kieseier BC, Nessler S, Hemmer B, Hartung HP, Stüve O. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol. 2007; 20 (3): 247-254.




2020     |     www.medigraphic.com